465 related articles for article (PubMed ID: 22686525)
1. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
Müller T; Hengstermann A
Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 protects against airway disorders.
Cho HY; Kleeberger SR
Toxicol Appl Pharmacol; 2010 Apr; 244(1):43-56. PubMed ID: 19646463
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation.
Blake DJ; Singh A; Kombairaju P; Malhotra D; Mariani TJ; Tuder RM; Gabrielson E; Biswal S
Am J Respir Cell Mol Biol; 2010 May; 42(5):524-36. PubMed ID: 19520915
[TBL] [Abstract][Full Text] [Related]
4. Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2.
Singh A; Rangasamy T; Thimmulappa RK; Lee H; Osburn WO; Brigelius-Flohé R; Kensler TW; Yamamoto M; Biswal S
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):639-50. PubMed ID: 16794261
[TBL] [Abstract][Full Text] [Related]
5. The transcriptome of Nrf2-/- mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes.
Gebel S; Diehl S; Pype J; Friedrichs B; Weiler H; Schüller J; Xu H; Taguchi K; Yamamoto M; Müller T
Toxicol Sci; 2010 May; 115(1):238-52. PubMed ID: 20133372
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
7. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
Stępkowski TM; Kruszewski MK
Free Radic Biol Med; 2011 May; 50(9):1186-95. PubMed ID: 21295136
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3.
Rojo AI; Medina-Campos ON; Rada P; Zúñiga-Toalá A; López-Gazcón A; Espada S; Pedraza-Chaverri J; Cuadrado A
Free Radic Biol Med; 2012 Jan; 52(2):473-87. PubMed ID: 22142471
[TBL] [Abstract][Full Text] [Related]
10. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
Uruno A; Motohashi H
Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
[TBL] [Abstract][Full Text] [Related]
12. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM
Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006
[TBL] [Abstract][Full Text] [Related]
13. Prolonged cigarette smoke exposure decreases heme oxygenase-1 and alters Nrf2 and Bach1 expression in human macrophages: roles of the MAP kinases ERK(1/2) and JNK.
Goven D; Boutten A; Leçon-Malas V; Boczkowski J; Bonay M
FEBS Lett; 2009 Nov; 583(21):3508-18. PubMed ID: 19822148
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies of the Nrf2-Keap1 signaling pathway.
Zhang DD
Drug Metab Rev; 2006; 38(4):769-89. PubMed ID: 17145701
[TBL] [Abstract][Full Text] [Related]
15. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
Hayes JD; McMahon M
Trends Biochem Sci; 2009 Apr; 34(4):176-88. PubMed ID: 19321346
[TBL] [Abstract][Full Text] [Related]
16. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
17. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation.
Bryan HK; Olayanju A; Goldring CE; Park BK
Biochem Pharmacol; 2013 Mar; 85(6):705-17. PubMed ID: 23219527
[TBL] [Abstract][Full Text] [Related]
18. Initial response and cellular protection through the Keap1/Nrf2 system during the exposure of primary mouse hepatocytes to 1,2-naphthoquinone.
Miura T; Shinkai Y; Jiang HY; Iwamoto N; Sumi D; Taguchi K; Yamamoto M; Jinno H; Tanaka-Kagawa T; Cho AK; Kumagai Y
Chem Res Toxicol; 2011 Apr; 24(4):559-67. PubMed ID: 21384861
[TBL] [Abstract][Full Text] [Related]
19. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones.
Mann GE; Bonacasa B; Ishii T; Siow RC
Curr Opin Pharmacol; 2009 Apr; 9(2):139-45. PubMed ID: 19157984
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
